Literature DB >> 19705261

HCV infection and cryptogenic cirrhosis are risk factors for hepatocellular carcinoma among Latinos in New York City.

Rafael Guerrero-Preston1, Abby Siegel, John Renz, David Vlahov, Alfred Neugut.   

Abstract

Latinos in the US experience a 60% higher death rate from primary hepatocellular carcinoma (HCC) when compared to Non-Latinos. The goal of this study was to examine risk factors that are associated with ethnic disparities among HCC patients seen at the transplant center of a metropolitan medical center in New York City. We compared HCC risk factors in 140 Non-Latino and 55 Latino patients that presented with HCC from 1995 to 2003. Surnames were used to define Latino and Non-Latino HCC patients in a retrospective analysis. Latino and Non-Latino HCC patients did not vary by gender or age at presentation (mean Latino age 60.8). Latino HCC patients had a higher frequency of presentation with advanced disease, defined as patients with unresectable HCC, than non Latino HCC patients (Latino 52.7%; 95% CI 39.1-66.3 vs. Non-Latino vs. 36.4%; 95% CI 28.3-44.4). Latinos were more likely than Non Latinos to have underlying HCV (34.5 vs. 22.1%, P < .0001; adjusted odds ratio [Siegel, 2008 #564], 3.69; 95% CI, 1.16-11.7) and cryptogenic liver diseases (7.2 vs. 3.5%, P < .0001; OR 8.86; 95% CI, 1.21-65.0) after adjusting for age, gender and alfa-fetoprotein levels. Although more advanced disease may signal delay in access to care or more aggressive disease, HCV infection and cryptogenic cirrhosis at presentation are likely key factors for the greater burden of HCC among Latinos in New York City.

Entities:  

Mesh:

Year:  2009        PMID: 19705261     DOI: 10.1007/s10900-009-9184-2

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  37 in total

1.  Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease.

Authors:  Garrett M Nash; Leonard B Saltz; Nancy E Kemeny; Bruce Minsky; Sunil Sharma; Gary K Schwartz; David H Ilson; Eileen O'Reilly; David P Kelsen; Daniel R Nathanson; Martin Weiser; Jose G Guillem; W Douglas Wong; Alfred M Cohen; Philip B Paty
Journal:  Ann Surg Oncol       Date:  2002-12       Impact factor: 5.344

2.  Use of geocoding in managed care settings to identify quality disparities.

Authors:  Allen M Fremont; Arlene Bierman; Steve L Wickstrom; Chloe E Bird; Mona Shah; José J Escarce; Thomas Horstman; Thomas Rector
Journal:  Health Aff (Millwood)       Date:  2005 Mar-Apr       Impact factor: 6.301

3.  Mortality and hospital utilization for hepatocellular carcinoma in the United States.

Authors:  W Ray Kim; Gregory J Gores; Joanne T Benson; Terry M Therneau; L Joseph Melton
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

4.  Hepatocellular carcinoma in Hispanics.

Authors:  Nahum Méndez-Sánchez; Daniel Zamora-Valdés; Francisco Vásquez-Fernández; Misael Uribe
Journal:  Ann Hepatol       Date:  2007 Oct-Dec       Impact factor: 2.400

5.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

Review 6.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 7.  Obesity and hepatocellular carcinoma.

Authors:  Stephen H Caldwell; Deborah M Crespo; Hyon Scott Kang; Abdullah M S Al-Osaimi
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

8.  Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.

Authors:  Adrian M Di Bisceglie; Andre C Lyra; Myron Schwartz; Rajender K Reddy; Paul Martin; Gregory Gores; Anna S F Lok; Khozema B Hussain; Robert Gish; David H Van Thiel; Zobair Younossi; Myron Tong; Tarek Hassanein; Luis Balart; Jacquelyn Fleckenstein; Stephen Flamm; Andres Blei; Alex S Befeler
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

9.  Epidemiology of hepatocellular carcinoma in Hispanics in the United States.

Authors:  Hashem B El-Serag; Melvin Lau; Karl Eschbach; Jessica Davila; James Goodwin
Journal:  Arch Intern Med       Date:  2007-10-08

10.  Seroprevalence of hepatitis C and associated risk factors among an urban population in Haiti.

Authors:  Matthew J Hepburn; Eric J Lawitz
Journal:  BMC Gastroenterol       Date:  2004-12-14       Impact factor: 3.067

View more
  2 in total

1.  Disparities in liver cancer incidence by nativity, acculturation, and socioeconomic status in California Hispanics and Asians.

Authors:  Ellen T Chang; Juan Yang; Theresa Alfaro-Velcamp; Samuel K S So; Sally L Glaser; Scarlett Lin Gomez
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-12       Impact factor: 4.254

Review 2.  Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma.

Authors:  Ramesh P Thylur; Sanjit K Roy; Anju Shrivastava; Thomas A LaVeist; Sharmila Shankar; Rakesh K Srivastava
Journal:  JGH Open       Date:  2020-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.